Original Article

You have full text access to this OnlineOpen article

Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program†‡

  1. Donatus U. Ekwueme PhD§,*,
  2. Ingrid J. Hall PhD, MPH,
  3. Lisa C. Richardson MD, MPH,
  4. James G. Gardner MSPH,
  5. Janet Royalty MS,
  6. Trevor D. Thompson BS

Article first published online: 5 JUN 2008

DOI: 10.1002/cncr.23613

Issue

Cancer

Cancer

Volume 113, Issue 3, pages 592–601, 1 August 2008

Additional Information

How to Cite

Ekwueme, D. U., Hall, I. J., Richardson, L. C., Gardner, J. G., Royalty, J. and Thompson, T. D. (2008), Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program. Cancer, 113: 592–601. doi: 10.1002/cncr.23613

Author Information

  1. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia

  1. §

    Fax: (770) 488-4639

*Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, MS K-55, Atlanta, GA 30341

  1. †

    The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

  2. ‡

    This article is a U.S. Government work and, as such, is in the public domain in the United States of America.

Publication History

  1. Issue published online: 18 JUL 2008
  2. Article first published online: 5 JUN 2008
  3. Manuscript Accepted: 20 MAR 2008
  4. Manuscript Revised: 14 MAR 2008
  5. Manuscript Received: 14 JAN 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (143K)

REFERENCES

  • 1
    Humphrey LL,Helfand M,Chan BK,Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137: 347–360.
  • 2
    U.S. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002; 137: 344–346.
  • 3
    Berry DA,Cronin KA,Plevritis SK, et al. Effects of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005; 353: 1784–1792.
  • 4
    Smith RA,Saslow D,Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin. 2003; 54: 141–169.
    Direct Link:
  • 5
    Zoorob R,Anderson R,Cefalu C,Sidani M. Cancer screening guidelines. Am Fam Physician. 2001; 63: 1101–1112.
  • 6
    Feig SA,Kopans DB,Sickles EA,Jackson VP,Monsees B. Rationale for annual screening mammography for women ages 40-49 years. Breast Dis. 1998; 10(3-4): 13–21.
  • 7
    Ayanian JZ,Weissman JS,Schneider EC,Ginsburg JA,Zaslavsky AM. Unmet health needs of uninsured adults in the United States. JAMA. 2000; 284: 2061–2069.
  • 8
    Ekwueme DU,Gardner JG,Subramanian S,Tangka FK,Bapat B,Richardson LC. Cost analysis of the National Breast and Cervical Cancer Early Detection Program—selected states. Cancer. 2008; 112: 626–635.
    Direct Link:
  • 9
    Ryerson AB,Bernard VB,Major AC. National Breast and Cervical Cancer Early Detection Program: 1991-2002 National Report. Atlanta, Ga: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2005. Available at: http://www.cdc.gov/cancer/nbccedp/Reports/NationalReports/index.htm. Accessed October 22, 2007.
  • 10
    Centers for Disease Control and Prevention. The National Breast and Cervical Cancer Early Detection Program. Available at: http://www.cdc.gov/cancer/nbccedp/about.htm. Accessed October 22, 2007.
  • 11
    Eheman CR,Benard VB,Blackman D, et al. Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States). Cancer Causes Control. 2006; 17: 29–38.
  • 12
    GoldMR,SiegelJE,RusselLB,WeinsteinMC, ed. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
  • 13
    Bobo JK,Shapiro JA,Schulman J,Wolters CL. On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program. Cancer Epidemiol Biomarkers Prev. 2004; 13: 620–630.
  • 14
    Peipins LA,Shapiro JA,Bobo JK,Berkowitz Z. Impact of women's experiences during mammography on adherence to rescreening (United States). Cancer Causes Control. 2006; 17: 439–447.
  • 15
    Shad B,Barnwell B,Bieler GS. SUDAAN Users Manual, Release 8.0, vol 1. Research Triangle Park, NC: Research Triangle Institute; 2001.
  • 16
    U.S. Census Bureau. Current Population Survey, 2001-2004. Annual Social and Economic Supplements. Special Income Tabulation for the Year 2000 and 2003. Washington, DC: U.S. Census Bureau; 2004.
  • 17
    U.S. Bureau of Labor Statistics. Consumer Price Indexes. Washington, DC: Bureau of Labor and Statistics; 2003. Available at: http://www.bls.gov/cpi/. Accessed October 22, 2007.
  • 18
    Grosse SD. Appendix I. Productivity loss tables. In: HaddixAC,TeutschSM,CorsoPS, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation,2nd ed. New York, NY: Oxford University Press; 2003: 245–257.
  • 19
    Lairson DR,Chan W,Newmark GR. Determinants of the demand for breast cancer screening among women veterans in the United States. Soc Sci Med. 2005; 61: 1608–1617.
  • 20
    Secker-Walker RH,Vacek PM,Hooper GJ,.Plante DA,Detsky AS. Screening for breast cancer: time, travel, and out-of-pocket expenses. J Natl Cancer Inst. 1999; 91: 702–708.
  • 21
    Schrank D,Lomax T. The 2002 Urban Mobility report. Available at: http://mobility.tamu.edu/ums/archive/report_list.stm#2002. Accessed October 22, 2007.
  • 22
    Guidry JJ,Aday LA,Zhang D, et al. Transportation as a barrier to cancer treatment. Cancer Pract. 1997; 5: 361–366.
  • 23
    Shireman TI,Tsevat J,Goldie SJ. Time costs associated with cervical cancer screening. Int J Technol Assess Health Care. 2001; 17: 146–152.
  • 24
    Frew E,Wolstenholme JL,Atkin W, et al. Estimating time and travel costs incurred in clinic based screening: flexible sigmoidoscopy screening for colorectal cancer. J Med Screen. 1999; 6: 119–123.
  • 25
    Yabroff KR,Davis WW,Lamont EB, et al. Patient time costs associated with cancer care. J Natl Cancer Inst. 2007; 99: 14–23.
  • 26
    Andersson A,Levin L-A,Emtinger BG. The economic burden of informal care. Int J Technol Assess Health Care. 2002; 18: 46–54.
  • 27
    Luce BR,Manning WG,Siegel JE,Lipscomb J. Estimating costs in cost-effectiveness analysis. In: GoldMR,SiegelJE,RusselLB,WeinsteinMC, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
  • 28
    General Services Administration. Federal travel regulations; privately owned automobile mileage reimbursement: final rule. Fed Reg. 2000; 65: 1267–1269.
  • 29
    U.S. Department of Transportation, Bureau of Transportation Statistics. National Transportation Statistics 2000. BTSO1-01. Washington, DC: U.S. Government Printing Office; 2001.
  • 30
    Rauscher GH,O'Malley MS,Earp JA. How consistently do women report lifetime mammograms at successive interviews? Am J Prev Med. 2002; 22: 8–14.
  • 31
    Makuc DM,Breen N,Messner HI,Vernon SW,Cohen A. Financial barriers to mammography: who pays out-of-pocket? J Womens Health. 2007; 16: 349–360.
  • 32
    Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics. 2000; 17: 479–500.
  • 33
    Doubilet P,Begg CD,Weinstein MC,Braun P,NcMeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making. 1985; 5: 157–177.
  • 34
    Vose D. Risk Analysis: A Quantitative Guide, 2nd ed. New York, NY: John Wiley & Sons, Ltd.; 2000.
  • 35
    Hurley SF,Livingston PM. Personal costs incurred by women attending a mammographic screening programme. Med J Aust. 1991; 154: 132–134.
  • 36
    Tangka FK,Dalaker J,Chattopadhyay SK, et al. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control. 2006; 17: 1145–1154.
  • 37
    Institute of Medicine. Mammography and Beyond. Washington, DC: National Academy Press; 2001.
  • 38
    Kiefe CI,McKay SV,Halevy A,Brody BA. Is cost a barrier to screening mammography for low-income women receiving Medicare benefits? A randomized trial. Arch Intern Med. 1994; 154: 1217–1224.
  • 39
    Blustein J. Medicare coverage, supplemental insurance, and the use of mammography by older women. N Engl J Med. 1995; 332: 1138–1143.
  • 40
    Zapka JG,Hosmer D,Costanza ME,Harris DR,Stoddard A. Changes in mammography use: economic, need, and service factors. Am J Public Health. 1992; 82: 1345–1351.
  • 41
    Urban N,Anderson GL,Peacock S. Mammography screening: how important is cost as a barrier to use? Am J Public Health. 1994; 84: 50–55.
  • 42
    Rimer BK,Conaway MR,Lyna PR, et al. Cancer screening practices among women in a community health center population. Am J Prev Med. 1996; 12: 351–357.
  • 43
    Breen N,Cronin KA,Meissner HI, et al. Reported drop in mammography: is this cause for concern? Cancer. 2007; 109: 2405–2409.
    Direct Link:
  • 44
    Centers for Disease Control and Prevention. Use of mammography among women aged ≥40 years—United States. MMWR Morb Mortal Wkly Rep. 2007; 56: 49–51.
  • 45
    Yabroff KR,Warren JL,Knopf K,Davis WW,Brown ML. Estimating patient time costs associated with colorectal cancer care. Med Care. 2005; 43: 640–648.
  • 46
    Lafata JE,Simpkins J,Lamerato L,Poisson L,Divine G,Johnson CC. The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev. 2004; 13: 2126–2132.
View Full Article (HTML) Get PDF (143K)